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Abstract
 Many different resources are needed  for analyzing rele-
vant experimental data in drug design. Currently this data is
difficult to access, because it is stored in heterogeneous data-
bases, spread over many platforms, poorly interconnected,
incomplete, erroneous, or just not electronically available. In
order to establish a high quality database for drug design we
have developed a new demand-driven methodology for inte-
grating and semantically enriching heterogeneous data from
different research areas and for migrating the data into an ob-
ject-oriented database management system. In this way we
have established a database containing well-prepared, rele-
vant data needed for drug design and offering the advantages
of modern database technology, like a comprehensive object-
oriented data model, a flexible declarative query language
and  support for persistent storage and sharing of data in a
multi-user environment.
1 Introduction
New biomolecular and computational methods have led
to an explosion in the available biomolecular data. Thus the
electronic management of large biomolecular databases
has become an important application area of computational
tools. The development of biomolecular databases is typi-
cally driven by the immediate needs of a particular research
task, e.g. structure elucidation of proteins. Therefore the
emerging databases are specialized and not necessarily
ready to use for other researchers. For example, drug de-
signers are interested in obtaining new insights into the in-
teraction of proteins and ligands by analyzing existing ex-
perimental data. The relevant data for this purpose is spread
over 3D structure databases, ligand databases or protein
mutation databases, just to name a few.
Within the national joint project RELIWE1, a research
consortium for the ”Computation and Prediction of Recep-
tor-Ligand Interaction”, in which EMBL Heidelberg and
GMD participate as research institutions and BASF, Lud-
1. This work is supported by the German ”Bundesministerium
für Bildung und Wissenschaft” BMBW, grant number
01IB302E.
wigshafen and E. Merck, Darmstadt, participate as indus-
trial partners, we aim at an integrated and flexible access to
the underlying, autonomous, heterogeneous information
bases and the integrated usage of different algorithmic
tools. One goal is to provide an integrated database that sat-
isfies the information needs of drug designers when they in-
vestigate the receptor-ligand docking problem.
During the analysis phase of the project it has turned out,
that the existing data is spread over different platforms in
different formats or is not available in electronic format at
all. A common data model as well as flexible and efficient
access mechanisms are missing. The data itself is often er-
roneous or incomplete, data in different databases is over-
lapping and sometimes inconsistent. Existing solutions
like hard-wired applications over file-based databases do
not solve these problems. We have decided to develop in
close collaboration with biomolecular scientists and drug
designers a system exploiting modern database technology.
In this way we achieve a unique high quality database,
which is of high interest for researchers in drug design and
relieves them from dealing with technical details as far as
possible.
As a platform we use an object-oriented database man-
agement system for two reasons. Using database manage-
ment technology provides different services for free, like
the support of a structured data model, flexible retrieval
mechanisms and persistent storage and sharing of data in a
multi-user environment. Object-oriented data models pro-
vide flexibility, expressiveness and extensibility. These
features are needed to adequately represent the complex
data occurring in research.
In this paper we want to report on the approach we are
taking in order to integrate the existing databases and other
available data. Existing approaches are not sufficient to
cover our requirements. In the computer science area of da-
tabase integration typically strong assumptions are made
on the resource databases, like the availability of database
schemas or query languages for these databases. The in-
tegration and enrichment of data is mainly treated on a
schema level, while the main difficulties in our project are
encountered when integrating existing data on an object
level. On a physical level these approaches are directed to
virtual access to the integrated data, while we need for per-
formance reasons direct physical access.
In the practice of biomolecular databases different ap-
proaches exist to integrate existing file-based databases.
Some integrate and enrich existing databases producing a
file-based database covering a particular specialized as-
pect, like SWISSPROT (Bairoch & Boeckmann 1991) for
protein sequences. Others integrate heterogeneous data-
bases using database management systems without seman-
tically integrating or enriching the data, like IGD (Ritter et
al. 1994) for genomic data. So we have developed our own
methodology for integrating and semantically enriching
heterogeneous data from different research areas, and for
migrating the data into an object-oriented database man-
agement system. Conceptually we follow the so-called fed-
erated database approach (Sheth & Larson 1990), where
existing databases are integrated by mapping their schemas
into one common integrated schema. During the integra-
tion process additional information in terms of complex
transformations, enrichments and relationships of the ex-
isting data need to be specified, which can only be done us-
ing a lot of specialized expert knowledge. Our methodolo-
gy allows the experts to specify this knowledge in an easy
yet formal way, such that an automated process can derive
the integrated database from this information.
We use the object-oriented DBMS VODAK developed
at GMD-IPSI as the basis for our prototype. It is the first da-
tabase that exploits the advantages of object-oriented data-
base management technology for realizing a value-added,
integrated database for research on drug design. First re-
sults show that the major benefits for the user are the provi-
sion of a semantically rich data model, mechanisms to sup-
port the integration and enrichment of existing data, and the
possibility of efficient and flexible access to the data by
means of a declarative query language. In particular some
of the advanced features of VODAK, like extensibility of
the data model as well as query language and processing,
prove to be useful.
The paper is organized as follows. In Section 2 we re-
view the current state in biomolecular databases. In Section
3 we discuss the requirements that have arisen in the RE-
LIWE project. In Section 4 we give a short account of the
VODAK database management system. Section 5 contains
the core of the paper by presenting the integration method-
ology. In Section 6 we illustrate the approach by means of
examples. We conclude in Section 7.
2 Data management in biomolecular 
chemistry
Biomolecular databases. Intensive research in the
field of molecular biology has lead to massive amounts of
heterogeneous data. Due to the fact that many of these data-
bases have emerged from the immediate needs of particular
research tasks, they often have a strong thematic binding to
a specialized area. Over hundred biomolecular databases
are known today. Their number and size is rapidly growing.
Typically these databases are file based, like PDB (Ni-
shikawa et al. 1977), SWISSPROT, or PIR (Barker et al.
1991), and make no use of the benefits that modern data-
base technology offers. A large part of the functionality,
like the support of a data model, the maintenance of integri-
ty constraints or the retrieval of data, are hard wired into ap-
plication programs. With regard to these functionalities the
resulting systems thus lack flexibility against modifica-
tions. This is a major drawback in a rapidly evolving re-
search area like molecular biology. In order to advance be-
yond purely file-based solutions, there have been attempts
to use relational database technology. SESAM (Huysmans
et al. 1991) and BIPED (Islam & Sternberg 1989) are built
on top of commercial relational database systems. A first
step in the direction of using object-oriented database
technology was made with P/FDM (Kemp et al. 1994), that
is based on a functional object oriented data model and is
implemented on top of PROLOG. Other object-oriented
approaches use C++ class libraries for accessing flat file
databases, like PDBTool (Chang et al. 1994), special pur-
pose object storage systems, like ACEDB (Durbin & Thier-
ry-Mieg 1994), or commercial C++ based object-oriented
database management systems, like MapBase (Goodman
1995).
Integration of biomolecular databases. Most of the
databases mentioned above focus on a particular kind of
data, like PDB on protein structures. On the other hand
these databases contain complementary and overlapping
information. Thus the integration of these databases be-
comes a major issue.
In the database community there exist several ap-
proaches, that address the issue of database integration.
Overviews can be found in (Sheth & Larson 1990), where
basic terminology is introduced, e.g. multidatabase sys-
tems, multidatabase languages or federated database sys-
tems. Besides the approaches from the more general data-
base-oriented viewpoint, there have been many projects
that focus directly on the biomolecular application domain.
In (Sillince & Sillince 1993) an overview over integration
efforts in the field is given, especially for integrating pro-
tein structure and sequence databases.
One approach is CAN/SND (Wood et al. 1989), the Ca-
nadian Scientific Numeric Database Service, that allows
common access to available online databases. Another ap-
proach is ISIS (Akrigg et al. 1988), the Integrated Sequence
Structure Database, that allows access to two integrated da-
tabases, namely OWL and BIPED. OWL is an integrated
sequence database from NBRF and SWISSPROT and con-
tains translated sequences from GenBank. BIPED contains
sequence and structure data by using the underlying rela-
tional database system ORACLE. Nentrez from NCBI of-
fers a client for local workstations that contacts an inte-
grated database server via the internet. The server database
integrates many biomolecular, medical and literature data-
bases and offers common access to these. IGD provides an
integrated genomic database (Ritter et al. 1994). Different
approaches provide integration on user interface level, like
XBio (Kamel et al. 1993).
3 Environmental characteristics
For the realization of our integrated database it is crucial
to consider the requirements of the users, both from indus-
trial and academic research. Our aim is to build up a high-
quality integrated protein-ligand database to support the
analysis of data, which is relevant for the investigation of
the receptor-ligand docking problem. The attribute high-
quality comprises two aspects of equal importance:
1. The contents of the database must be of high quality.
This is achieved by combining different information
resources, correcting the data from these resources
and enriching it by data, that is electronically not
available.
2. The access to the database must be of high quality.
This is achieved by of enabling an easy understanding
of the available data and operations, providing flex-
ible retrieval capabilities to support user requests,
and efficient processing of these requests.
From the existing environment the following require-
ments have been derived.
Use of preexisting data. We want to use preexisting
data as far as possible. A minimal requirement is to provide
data from the PDB, SWISSPROT, PIR protein databases
and from the (proprietary) MACCS small molecule data-
base used in pharmaceutical research. Additionally we use
DSSP-files for secondary structure definitions and HSSP-
files for alignments. One common property of all these
public and proprietary databases is, that they are autono-
mous. This means that we cannot exert any control on these
databases. We have to consider updates and versions of the
external databases.
Enrichment and preparation of data. Due to lack of
structure, different nomenclatures and possibly errors, for
our purposes the publicly available data is not ready for use.
Thus we must perform transformations, e.g. for different
numbering schemes for residues in sequences and struc-
tures. Some of them can be done automatically, others must
be carried out manually. Correcting and subsequently com-
bining data from different databases is a challenging, intel-
lectual task, that can only performed by an expert from the
area. This process also includes an appropriate selection of
data, as the available databases may also contain data we
are not interested in.
Addition of data. Data that is not available in electronic
form has to be supplemented. Some of the data must be add-
ed manually, e.g. from the scientific literature, other data is
provided by applying computational analysis to existing
data,  e.g. computing bond information from spatial coordi-
nates and atom types.
Considering the whole integration process human inter-
action is an expensive subtask, compared to other subtasks,
that can be dealt with in an automated fashion.
Data access. The ultimate goal of the whole process is to
enable a flexible and powerful access to the data of interest.
This access must relieve the user from details of how the
data is physically accessed. It must be supported by power-
ful processing mechanism, that can also efficiently deal
with unanticipated requests. This is not possible in most
current systems, where queries cannot freely be formu-
lated. Data access must be based on an easily understand-
able, yet expressive, model of the data.
Updates. Improving, augmenting and processing the
preexisting data leads to derived data in the database. Up-
dates on external databases have to be maintained in the in-
tegrated database in a consistent way. We have also to con-
sider updates on  the integrated database, e.g. users who are
storing the result of their work and who wish to use those in
queries in combination with the standard database content.
These updates have to be preserved in the case of propaga-
tion of updates of an external database. Immediate propa-
gation of updates is a minor issue. As we are not aiming at a
publicly available online database, it is reasonable to close
down the database for expensive update operations.
4 The OODBMS VODAK
The protein ligand database is implemented on top of
the object-oriented database management system VODAK
release 4.0 (VODAK 1995) developed at GMD-IPSI. The
object-oriented data model is accepted to be appropriate for
flexible modelling of the complex structures and opera-
tional semantics, that are needed for non-standard database
application scenarios like molecular biology. VODAK pro-
vides full database management system functionality, in-
cluding schema compiler, transaction management, object
management, data dictionary, communication
management and query processing. It runs on top of
ObjectStore, which is used for low-level storage.
Different features make VODAK particularly attractive
for our purposes. The object-oriented data model VML
(Klas et al. 1994) provides a metaclass concept for tailoring
the datamodel to specific application domains. Thus se-
mantic concepts that are characteristic for an application
domain can be provided as new data modelling primitives,
which extend the core data model. The declarative SQL-
like query language allows the usage of method calls and
path expressions within queries, and thus enables flexible
and intuitive access to the database. A powerful, extensible
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Figure 1: The conceptual database schema
query optimization module, based on algebraic optimiza-
tion techniques, allows to incorporate application-specific
optimization strategies, which are particularly important
when complex calculations or expensive access operations
to external databases are involved in declarative queries.
5 Database Integration Approach
Schema Integration. In the following we adhere to the
terminology that is used in the five-level architecture of the
federated database systems approach. Within our project
first a conceptual schema  has been defined intellectually in
a collaboration of computer scientists and biomolecular
and biochemical experts (Figure 1). Due to the expressive-
ness of the object-oriented data model it is relatively
straightforward to map this model into an object-oriented
integrated database schema. This is the target schema
against which users pose queries. The different  local data-
base schemas of the external databases need to be trans-
lated to the common data model. This leads to the compo-
nent schema, which provides for each external database a
corresponding representation in the database system.
These classes provide database methods for accessing in-
formation from external files. Finally a mapping from the
component schema to the integrated schema is defined.
General Integration Methodology. The integration
process is decomposed into two phases, as depicted in Fig-
ure 2. In the first phase, the biomolecular-oriented specifi-
cation and preparation phase (BP), data is prepared under
biomolecular and biochemical aspects and in the second
phase, the data-management-oriented integration phase
(DP), the data is integrated within a database management
system. In the BP we want to remain as flexible as possible,
thus we perform processing outside the particular DBMS in
use. In the DP we make full use of the processing capabili-
ties of the DBMS. The result of the BP is used as input to the
DP and consists of a set of intermediate files. These files
contain (1) corrected data from existing file databases, (2)
value-added data that has been prepared computationally
from existing data or made available electronically and (3)
a specification of how to integrate this data into one inte-
grated database, the so-called import specification. This
data is independent of the database system used. Processing
in the BP is inherently semi-automatic – although eventual-
ly most of the steps are handled algorithmically and manual
intervention is needed for few special cases – while proces-
sing in the DP can be completely automated and is uniquely
specified by the data provided in the BP.
This two phase integration methodology leads to a clear
separation of application-specific and database-specific
problems, which meets existing spatial and personal
constraints and allows independent evolution of the tech-
niques used in the two phases. This approach turned out to
be necessary in order to achieve within the project rapid
progress.
Biomolecular and biochemical data enrichment and
integration. At the beginning of the BP data is either avail-
able in electronic form, on paper or in the heads of the re-
searchers. The task within the BP is to prepare and combine
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Figure 2: Two phase database integration
this information in a form and quality, allowing to apply
data management techniques. This involves the subtasks of
definition of the database content, i.e. identifying and se-
lecting the data that will be needed in the integrated pro-
tein-ligand database, the addition and correction of data
(needed for semantic enrichment), and the identification of
relationships between data (needed for semantic integra-
tion).
The BP is a combination of intellectual and automatable
steps. The question what can be handled algorithmically,
and what particular algorithms can be applied, can only be
answered by a person with deep expertise in the field.
Therefore, from a data management point of view, at the
current stage one can support this process only by provid-
ing a well-defined interface for specifying the knowledge
gained in this process and provide it as input to the DP.
When the project has progressed, one is in the position to
look for patterns that are usable to reach a general method-
ology for the BP.
The syntactical representation of the corrected data and
value-added data is predetermined by pragmatic
constraints. Whenever there preexists a format we use this,
e.g. in the case of corrected PDB data, and for the value-
added data we use formats that are similar to those of exist-
ing file databases.
The import specification. The import specification is
needed to define the mapping of the data in the external da-
tabases to the integrated database on an object level. For the
import specification we have defined a specification lan-
guage. The language is tailored to the needs of later proces-
sing, i.e. it can be easily parsed, can be edited by humans
and can be easily extended. It resembles in its syntactical
format the formats of the existing databases, which simpli-
fies handling by the expert from the field. An example is
given in Figure 3. It allows to express the different func-
tionalities needed for integration. Possible actions that can
be specified are
1. Generation of a new object in the integrated database.
2. Mapping of an external object to an object of the inte-
grated database.
3. Establishment of relationships between objects of the
integrated database.
4. Addition of data to objects of the integrated database.
5. Correction of attributes of objects of the integrated
database.
# specification of a protein ligand complex
Ligand: FCA
LigandModel: FCA lm1 FCA.mol2
Protein: 1abf
ProteinModel: 1abf pm1 pdb1abf.ent 1
Chain:   1abf – ARAF_ECOLI.sw
SecondaryStructure: 1abf – m1 pdb1abf.dssp
Complex: c1
ComplexProtein: c1 1abf
ComplexLigand: c1 FCA
# specification of additional data
ProteinOrganism:pdb1abf ESCHERICHIA COLI
ProteinKW: pdb1abf TRANSPORT; PERIPLASMIC;
# specification of corrections
ModelCorrection:1abf m1 1 2315 23
SSCorrection: 1abf – m1 1 304 25
Figure 3: Import specification
The user who is fluent with the integrated schema and
the available external databases can easily capture the se-
mantics of the different actions. Certain constraints have to
be observed within the import specification, e.g. only ob-
jects may be interlinked or corrected which have been pre-
viously generated. Conflicts occurring due to overlapping
instances in external databases must be resolved manually
within the import specification.  In order to support the user
when editing this data appropriate tools are envisaged, e.g.
for maintaining consistency constraints.
Generation of the import specification. Besides the
preparation and correction of existing file-based databases
the generation of the import specification is the most im-
portant step in the BP. In the following we describe a con-
crete example of how data is prepared for generating the
import specification.
A considerable  fraction of the PDB entries also contains
the coordinates of bound ligands. In order to identify these
receptor-ligand complexes we have realized a parser which
scans the entire PDB database for small molecules such as
substrates, inhibitors, cofactors, prosthetic  groups and
metal ions. Solvent molecules and molecules which are
covalently linked to  the receptor are ignored. Identified re-
ceptor-ligand complexes are entered in the import specifi-
cation and cross-referenced with other objects in the data-
base (Figure 4).
For processing the receptor proteins in a first phase the
parser extracts the coordinates of each receptor atom and
the amino acid sequence. Missing atoms, chain breaks are
identified and reported. Solvent accessibility and
secondary structure are calculated by executing the DSSP-
program (Kabsch & Sander 1983). In a second phase the
parser produces for each chain of the receptor cross-refer-
ences to the following databases: SWISSPROT, the protein
Figure 4: Generation of the import specification in the BP
(shaded boxes indicate data whereas white boxes indicate
processes).
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sequence database, PIR, the protein sequence database of
the Protein Identification Resource, EMBL (Higgins et al.
1992), PROSITE, the dictionary of  Protein Sites and
Patterns (Bairoch 1992) and PMD, the protein mutant data-
base. Cross-references are used to scan the SWISSPROT
and PMD databases for the following additional
information:
• Sequence conflicts: The parser compares the sequence
of each chain of the receptor with the  corresponding
sequence from SWISSPROT for conflicts such as
insertion and deletions, residues missing due to
disorders, conflicting and ambiguous experimental
results (e.g. amino acids typed as ASX, GLX or UNK).
• Mutations and modifications: For each receptor chain
the parser searches SWISSPROT and PMD for
information about mutations and modifications (e.g.
acylation, glycosylations or phorphorylations).
Sequential position, type of mutation or modification
and influence on stability or function are extracted.
Sequential positions of mutations and modifications
from the  SWISSPROT and PMD databases are
automatically converted to the PDB sequence
numbering system.
For processing the ligands, they are identified by
searching PDB-files for HETATM-records. Trivial names
are extracted from the HET-records. If present, the CON-
ECT-records are used to determine the connectivity of the
ligand atoms. If CONECT-records are absent, the
connectivity is derived from the interatomic distances. In
order to facilitate a detailed analysis of the molecular
interaction between ligands and receptors bonding orders
and hybridisation states are derived from bond lengths and
bond angles and checked for correctness manually (Barber
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Figure 5: Realisation of the database integration (DP)
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& Hodgkin 1992) (Meng & Lewis 1991). Finally the
ligands are transformed to the MOL2-format of MDL.
Data integration.  In the DP the following tasks have to
be performed.
(1) syntactical transformation, i.e. parsing of the textual
representations, in order to generate object-oriented
data structures according to the component schemas,
that can be processed by the DBMS.
(2) semantic enrichment, i.e. using the modelling mech-
anisms that the DBMS offers, in order to provide a se-
mantically rich representation of the data to improve
the efficiency of processing for retrieval.
In most realizations of the federated database approach
the existing databases are only virtually integrated, i.e. the
integrated database obtains data from the external data-
bases on request (’call by need’). In our case there exists no
fine-grained access to the external databases. Thus iterated
parsing of external files for obtaining small units of in-
formation or repetitive computation of complex trans-
formations would be required. As the import specification
is declarative, it does not specify how data integration is to
be performed operationally. So we choose to physically
replicate the data, i.e. actively populate the integrated data-
base in a ’forward driven’ manner.   (For other reasons sup-
porting physical migration of data in the context of feder-
ated database systems see, e.g., (Radeke & Scholl 1994)).
The population of the integrated database proceeds as
follows. A top level procedure realized as database method
in the component schema interprets the import specifica-
tion. Each statement in the import specification triggers an
appropriate method call in the database. For example a
mapping from an external object to an object of the inte-
grated database is realized by a method initiating a parsing
procedure on the corresponding external file, creating the
representative object in the component schema and then
instantiating the corresponding object(s) in the integrated
schema. Within this method index structures may be set up
and integrity constraints within the database are checked.
Objects of the component and integration schema are
linked appropriately, such that for every data item its origin
can be derived. This is essential for keeping track of up-
dates in the external databases. These updates lead to a re-
load of the replicated data, occur however only rarely.
Implementation. The implementation of the integrated
database is done on top of the OODBMS VODAK using
VML for specifying the database schema. In several meth-
od implementations external C++ code was used. Current-
ly the database contains 1495 proteins, 2613 chains and
secondary structures, 559 ligands in 1906 protein-ligand
complexes and 1536 metal-ion complexes. There are 1195
chain modifications and 5096 chain mutations loaded. The
integrated database containing all replicated objects occu-
pies about 500 MB diskspace.
6 Examples
A sample population step. Figure 6 illustrates the se-
mantic enrichment of chain and protein data. The implicit
knowledge, that a particular SWISSPROT chain occurs
twice in a protein is formulated explicitly in the specifica-
tion file (load.vcl in Figure 6). This results in the following
representation in the integrated schema: the chain object
derived from SWISSPROT, is specialized to two protein-
chain objects (specialization is indicated by a broken ar-
row). The two protein-objects can then occur as part of a
protein. They are existence-dependent on the protein they
belong to and cannot be shared by other proteins. 
A sample query. In this section we want to give an im-
pression of the querying capabilities one obtains with our
Protein: 1aaz
ProteinOrganism: bacteriophage T4
Chain: thio thio_bpt4.sw
ProteinChain: 1aaz thio A
ProteinChain 1aaz thio B
Protein
name: ’1aaz’
organism: ’bacteriophage T4’
Chain
name: ’thio’
sequence: ’MFKV....’
ProteinChain
name: A
protein:
ProteinChain
name: B
protein:
SwissProt
filename: ’thio_bpt4.sw’
VCL
filename: ’load.vcl’
thio_bpt4.sw
ID   THIO_BPT4      STANDARD;      PRT;
87 AA.
AC   P00276;
SQ   SEQUENCE   87 AA;  10050 MW;
38774 CN;
MFKVYGYDSN IHKCVYCDNA
KRLLTVKKQP FEFINIMPEK GVFDDEKIAE
LLTKLGRDTQ IGLTMPQVFA //
load.vcl
methods: parse()methods: parse()
Integrated schema
Component Schema
Figure 6: Populating the database with a multichain protein.
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approach. The example query illustrates (i) the possibility
to access protein and ligand data that has been previously
stored in separated databases, (ii) the ability to navigate in
the integrated schema, and (iii) the usage of complex algo-
rithms within the query.
The task of the query is to find all complexes that are
similar to a particular protein-ligand complex. Similarity
between complexes is expressed by a high chain homology
of the involved protein chains and a common substructure
of the involved ligands. The computation of the homology
(by the Needleman/Wunsch algorithm) and substructure
search is done via algorithms that are available within the
database system. The result of the query are the names of
complexes found.
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The  clause specifies the desired output (i.e. the
complex name). The  clause allows to bind variable
names to sets of objects, either specified by classes or
reached by navigation. The !" clause provides the
selection condition. We are interested in a special protein
(

## $%&$) and we are searching the homolo-
gous ones (()!	
*	
+)#,- ).
The ligand of the complex must have the specified sub-
structure given in Smiles code format (i.e. 	()/
...
*$*#+$+ ). Path expressions allow to navi-
gate along related classes by following links, e.g. /
	

 (compare also Figure 1).
7 Conclusion
We have presented an approach for building a high qual-
ity receptor-ligand information base for drug design. This
is the first approach that makes data from heterogeneous re-
sources from biomolecular and biochemical research
available in an integrated and enriched way within an ob-
ject-oriented database management system. For this pur-
pose we had to develop our own integration methodology.
We have arrived at a working system that opens the way
for further research. The process of data preparation needs
to be further investigated in order to be able to support this
phase with appropriate tools. With regard to data proces-
sing, in particular the investigation of application-specific
optimizations strategies for queries will be in the center of
interest. For supplementary information, like literature da-
tabases, where performance is a minor issue, external data-
bases will be integrated virtually.
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